NHLBI Umbilical Cord Blood Unit Collection (CBB) - Catalog
NHLBI Umbilical Cord Blood Unit Collection (CBB)
HLB01880909a
CBB
(COBLT) Cord Blood Transplantation Study (COBLT)
COBB
False
False
True
Anonymized
False
Epidemiology Study
Open BioLINCC Study
Pediatric
Procedure: stem cell transplantation
None
2009-10-01
2009-08-24
None
1998-2001
DBDR
Transfusion Medicine
non-HIV
non-COVID
132
0
Not Applicable (Specimens Only)
Not Applicable (Specimens Only)
Yes
Yes
Yes
Yes
Restrictions prohibit the use of biospecimens for cell line production. A subset of biospecimens are available for infectious disease testing. Biospecimens are not available for commercial use.
Anemia, Aplastic
Fanconi Anemia
Hematologic Diseases
Hematopoietic Stem Cell Transplantation
Leukemia
Myelodysplastic Syndromes
Neoplasms
Severe Combined Immunodeficiency
The NHLBI Umbilical Cord Blood Unit Collection parent study is the Cord Blood Transplantation Study Cord Blood Banking (COBLT CBB) program. The objective of the COBLT CBB was to build an ethnically diverse unrelated cord blood bank and to develop standard operating procedures for umbilical cord blood donor recruitment, selection and banking.
Cord blood is an alternative source of hematopoietic stem cells that has been shown to be efficacious in hematopoietic stem cell transplantation of both adults and pediatrics. Compared to other stem cell sources, cord blood is easier and safer to procure, has no donor attrition and can be stored and made readily available. Cord blood is rich in hematopoietic progenitor cells and antigen-inexperienced T cells. Transplantation of cord blood units are associated with reduced viral transmission, less acute and chronic graft-versus-host-disease than other stem cell sources. However, transplantation of cord blood also has been associated with delayed neutrophil and platelet engraftment, prolonged immune reconstitution, uncertain graft-versus-tumor activity, and cell doses from single cord blood units are a limiting factor for larger recipients.
The CBU were collected under standard operating procedures described in detail elsewhere (1) (https://web.emmes.com/study/cord/).
The CBU were collected under standard operating procedures described in detail elsewhere (1) (https://web.emmes.com/study/cord/).
J. K. Fraser et al., J Hematother 7, 521 (Dec, 1998).
M. S. Cairo et al., Transfusion 45, 856 (Jun, 2005).
J. Kurtzberg et al., Transfusion 45, 842 (Jun, 2005).
Cord Blood Aliquot
Cord Blood Unit
Please note that biospecimen availability is subject to review by the NHLBI, BioLINCC, and the NHLBI Biorepository. Certain biospecimens may not be made available for your request. Section 3 of the BioLINCC handbook describes the components of the review process
-
Material Types
-
General Freeze/Thaw Status
-
Visits (Vials)
Last Modified: Nov. 1, 2022, 1:55 p.m. -
Visits (Subjects)
11/01/2022
Subjects only have specimens from one time point.Cord Blood Aliquot Total number of subjects Average volume (ml) per subject Caucasian 1,154 1.74 Black/African 466 1.96 Asian/Pacific Islander 596 1.99 Hispanic 1,425 1.68 Other/Mixed 571 1.96 Cord Blood Unit Total number of subjects Average bags per subject Caucasian 185 1.00 Black/African 392 1.00 Asian/Pacific Islander 326 1.00 Hispanic 750 1.00 Other/Mixed 279 1.00
Last Modified: Nov. 1, 2022, 1:55 p.m.